Merck (MRK) EBITDA Margin (2009 - 2026)
Merck's EBITDA Margin was 6.02% in Q2 2026, down 32.65 percentage points from 38.66% a year earlier but up 17.58 percentage points from the prior quarter.
Powered by 
Analysis
Merck (MRK) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Merck's EBITDA Margin was 19.67% through Jun 30, 2026, down 17.56 percentage points year-over-year; for FY2025, it was 41.62%, up 3.58 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +21.17 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 38.04% in FY2024 (-13.95 pp), 52.00% in FY2023 (+15.13 pp), 36.86% in FY2022 (+4.48 pp) and 32.39% in FY2021 (+11.94 pp).
- Quarterly EBITDA Margin has moved between -28.33% (Q2 2023) and 44.86% (Q1 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of -9.11 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2024 (a gain of 72.90 percentage points); the worst was Q2 2023 (a drop of 68.51 percentage points).
- Per Business Quant data, MRK's EBITDA Margin in the three quarters before Q2 2026 was -11.57% (Q1 2026), 38.52% (Q4 2025) and 44.34% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Vertex Pharmaceuticals | 133.33 Bn | 105.34 Bn | 2.84 Bn | 39.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.02% |
| Mar 31, 2026 | -11.57% |
| Dec 31, 2025 | 38.52% |
| Sep 30, 2025 | 44.34% |
| Jun 30, 2025 | 38.66% |
| Mar 31, 2025 | 44.86% |
| Dec 31, 2024 | 35.16% |
| Sep 30, 2024 | 30.70% |
| Jun 30, 2024 | 44.56% |
| Mar 31, 2024 | 41.97% |
| Dec 31, 2023 | 21.35% |
| Sep 30, 2023 | 42.35% |
| Jun 30, 2023 | -28.33% |
| Mar 31, 2023 | 32.65% |
| Dec 31, 2022 | 31.31% |
| Sep 30, 2022 | 33.23% |
| Jun 30, 2022 | 40.18% |
| Mar 31, 2022 | 42.07% |
| Dec 31, 2021 | 32.78% |
| Sep 30, 2021 | 42.38% |
API Access
Merck EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();